Study to Compare the Safety and Efficacy of IDP-123 Lotion to Tazorac Cream in the Treatment of Acne Vulgaris

PHASE2UnknownINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Acne Vulgaris
Interventions
DRUG

IDP-123 Lotion

Investigational Product: IDP-123 Lotion

DRUG

Tazorac Cream, 0.1%,

Comparator Product: Tazorac Cream, 0.1%

DRUG

Vehicle Cream

Comparator Product: Vehicle Cream

DRUG

Vehicle Lotion

Comparator Product: Vehicle Lotion

Sponsors
All Listed Sponsors
lead

Valeant Pharmaceuticals

INDUSTRY

NCT02525822 - Study to Compare the Safety and Efficacy of IDP-123 Lotion to Tazorac Cream in the Treatment of Acne Vulgaris | Biotech Hunter | Biotech Hunter